BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 12015212)

  • 41. Receptor reserve analysis of the human alpha(2C)-adrenoceptor using.
    Umland SP; Wan Y; Shah H; Billah M; Egan RW; Hey JA
    Eur J Pharmacol; 2001 Jan; 411(3):211-21. PubMed ID: 11164378
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hetero-oligomers of alpha2A-adrenergic and mu-opioid receptors do not lead to transactivation of G-proteins or altered endocytosis profiles.
    Zhang YQ; Limbird LE
    Biochem Soc Trans; 2004 Nov; 32(Pt 5):856-60. PubMed ID: 15494033
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Analysis of functional selectivity through G protein-dependent and -independent signaling pathways at the adrenergic α(2C) receptor.
    Kurko D; Kapui Z; Nagy J; Lendvai B; Kolok S
    Brain Res Bull; 2014 Aug; 107():89-101. PubMed ID: 25080296
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fish somatostatin sst3 receptor: comparison of radioligand and GTPgammaS binding, adenylate cyclase and phospholipase C activities reveals different agonist-dependent pharmacological signatures.
    Siehler S; Nunn C; Zupanc GK; Hoyer D
    Auton Autacoid Pharmacol; 2005 Jan; 25(1):1-16. PubMed ID: 15659149
    [TBL] [Abstract][Full Text] [Related]  

  • 45. h5-HT(1B) receptor-mediated constitutive Galphai3-protein activation in stably transfected Chinese hamster ovary cells: an antibody capture assay reveals protean efficacy of 5-HT.
    Newman-Tancredi A; Cussac D; Marini L; Touzard M; Millan MJ
    Br J Pharmacol; 2003 Mar; 138(6):1077-84. PubMed ID: 12684263
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Desensitization of alpha 2A-adrenoceptor signalling by modest levels of adrenaline is facilitated by beta 2-adrenoceptor-dependent GRK3 up-regulation.
    Bawa T; Altememi GF; Eikenburg DC; Standifer KM
    Br J Pharmacol; 2003 Mar; 138(5):921-31. PubMed ID: 12642394
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Involvement of α2-adrenoceptor subtypes A and C in glucose homeostasis and adrenaline-induced hyperglycaemia.
    Ruohonen ST; Ruohonen S; Gilsbach R; Savontaus E; Scheinin M; Hein L
    Neuroendocrinology; 2012; 96(1):51-9. PubMed ID: 22327786
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characterization of human recombinant alpha(2A)-adrenoceptors expressed in Chinese hamster lung cells using extracellular acidification rate changes.
    MacLennan SJ; Reynen PH; Martin RS; Eglen RM; Martin GR
    Br J Pharmacol; 2000 Apr; 129(7):1333-8. PubMed ID: 10742288
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of ligand binding affinities at human I1-imidazoline binding sites and the high affinity state of alpha-2 adrenoceptor subtypes.
    Piletz JE; Zhu H; Chikkala DN
    J Pharmacol Exp Ther; 1996 Nov; 279(2):694-702. PubMed ID: 8930173
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Activation of guanosine 5'-[gamma-(35)S]thio-triphosphate binding through M(1) muscarinic receptors in transfected Chinese Hamster ovary cell membranes: 2. Testing the "two-states" model of receptor activation.
    Waelbroeck M
    Mol Pharmacol; 2001 Apr; 59(4):886-93. PubMed ID: 11259634
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antagonists that differentiate between alpha 2A-and alpha 2D-adrenoceptors.
    Trendelenburg AU; Wahl CA; Starke K
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Feb; 353(3):245-9. PubMed ID: 8692278
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Actions of alpha2 adrenoceptor ligands at alpha2A and 5-HT1A receptors: the antagonist, atipamezole, and the agonist, dexmedetomidine, are highly selective for alpha2A adrenoceptors.
    Newman-Tancredi A; Nicolas JP; Audinot V; Gavaudan S; Verrièle L; Touzard M; Chaput C; Richard N; Millan MJ
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Aug; 358(2):197-206. PubMed ID: 9750005
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. II. Agonist and antagonist properties at subtypes of dopamine D(2)-like receptor and alpha(1)/alpha(2)-adrenoceptor.
    Newman-Tancredi A; Cussac D; Audinot V; Nicolas JP; De Ceuninck F; Boutin JA; Millan MJ
    J Pharmacol Exp Ther; 2002 Nov; 303(2):805-14. PubMed ID: 12388667
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Constitutive precoupling to G(i) and increased agonist potency in the alpha(2B)-adrenoceptor.
    Ge H; Scheinin M; Kallio J
    Biochem Biophys Res Commun; 2003 Jul; 306(4):959-65. PubMed ID: 12821136
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of hippocampal alpha(2A)-adrenergic receptor in methamphetamine-induced hyperlocomotion in the mouse.
    Nishio M; Kuroki Y; Watanabe Y
    Neurosci Lett; 2003 May; 341(2):156-60. PubMed ID: 12686389
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Supersensitivity to mu-opioid receptor-mediated inhibition of the adenylyl cyclase pathway involves pertussis toxin-resistant Galpha protein subunits.
    Mostany R; Díaz A; Valdizán EM; Rodríguez-Muñoz M; Garzón J; Hurlé MA
    Neuropharmacology; 2008 May; 54(6):989-97. PubMed ID: 18384820
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Signal transduction correlates of mu opioid agonist intrinsic efficacy: receptor-stimulated [35S]GTP gamma S binding in mMOR-CHO cells and rat thalamus.
    Selley DE; Liu Q; Childers SR
    J Pharmacol Exp Ther; 1998 May; 285(2):496-505. PubMed ID: 9580589
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Differential activation of Gq/11 and Gi(3) proteins at 5-hydroxytryptamine(2C) receptors revealed by antibody capture assays: influence of receptor reserve and relationship to agonist-directed trafficking.
    Cussac D; Newman-Tancredi A; Duqueyroix D; Pasteau V; Millan MJ
    Mol Pharmacol; 2002 Sep; 62(3):578-89. PubMed ID: 12181434
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Influence of receptor number on functional responses elicited by agonists acting at the human adenosine A(1) receptor: evidence for signaling pathway-dependent changes in agonist potency and relative intrinsic activity.
    Cordeaux Y; Briddon SJ; Megson AE; McDonnell J; Dickenson JM; Hill SJ
    Mol Pharmacol; 2000 Nov; 58(5):1075-84. PubMed ID: 11040056
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mechanism of action of Gq to inhibit G beta gamma modulation of CaV2.2 calcium channels: probed by the use of receptor-G alpha tandems.
    Bertaso F; Ward RJ; Viard P; Milligan G; Dolphin AC
    Mol Pharmacol; 2003 Apr; 63(4):832-43. PubMed ID: 12644584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.